Vardenafil significantly alleviates erectile dysfunction in aged men with diabetes.
- Author:
Zhong-Lin ZHANG
1
;
Huo-Jin LI
;
Wan-Hua ZHEN
;
Rong YUAN
Author Information
- Publication Type:Journal Article
- MeSH: Aged; Aging; physiology; Diabetes Mellitus, Type 2; complications; Erectile Dysfunction; drug therapy; etiology; physiopathology; Humans; Imidazoles; therapeutic use; Male; Middle Aged; Phosphodiesterase Inhibitors; therapeutic use; Piperazines; therapeutic use; Sulfones; therapeutic use; Treatment Outcome; Triazines; therapeutic use; Vardenafil Dihydrochloride
- From: National Journal of Andrology 2008;14(8):737-739
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the efficacy and safety of vardenafil in the treatment of erectile dysfunction (ED) in aged men with diabetes mellitus (DM).
METHODSOne hundred outpatients with diagnosed ED (40 diabetic and 60 non-diabetic) received vardenafil at the initial dose of 20 mg and sustained dose of 10 mg once a week for 8 weeks, and their erectile functions were evaluated by IIEF and EQS.
RESULTSThe scores on IIEF and EQS in the diabetic ED group were 18.9 +/- 0.2 and 25.1 +/- 1.4 after the vardenafil treatment, significantly higher than 8.1 +/- 0.5 and 9.1 +/- 1.3 before the treatment (P < 0.01), and the non-diabetic group scored 21.1 +/- 0.2 and 34.2 +/- 1.2 on IIEF and EQS after the treatment, as compared with the statistically lower scores of 10.1 +/- 0.3 and 10.1 +/- 1.7 before it (P < 0.01). The total rate of effectiveness was 65% in the diabetic and 73.30% in the non-diabetic group, with statistical differences (P < 0. 05).
CONCLUSIONVardenafil can significantly improve erectile function and is well tolerated in the aged males with diabetic ED.
